Akt

Akt inhibitors target Akt, also called protein kinase B (PKB), a serine/threonine kinase in cell survival signaling. In 1995 the Akt proto-oncogene product was identified as a target of phosphatidylinositol 3-kinase (PI3K) activated by platelet-derived growth factor. Insulin and insulin-like growth factor 1 activate the kinase through phosphorylation at Thr308 and Ser473. The three isoforms, Akt1, Akt2 and Akt3, phosphorylate substrates that control metabolism, proliferation and apoptosis. The category includes the allosteric inhibitor MK-2206 2HCl, the catalytic-site inhibitor capivasertib and the alkylphospholipid perifosine. SC79, by contrast, promotes Akt phosphorylation and serves as an activator in pathway studies.

Items 126-150 of 158

  • 24-Methylenecycloartanyl ferulate
    Cat. No.
    A25871

    24-Methylenecycloartanyl ferulate

    24-Methylenecycloartanyl ferulate is identified as a potential ATP-competitive inhibitor of Akt1, with an EC50 value of 33.3 μM. This compound has been shown to promote the expression of parvin-beta in human breast cancer cells, suggesting its role in modulating important signaling pathways. As a research tool, it may be valuable for studying Akt1-related biological processes and their implications in cancer research.

    5 mg
    $190.00
    10 mg
    $300.00
    All 2 sizes
  • AKT-IN-3
    Cat. No.
    A25882

    AKT-IN-3

    AKT-IN-3 is a potent and selective AKT inhibitor that primarily targets the Akt signaling pathway, exhibiting IC50 values of 1.4 nM, 1.2 nM, and 1.7 nM for Akt1, Akt2, and Akt3, respectively. This compound also demonstrates significant inhibitory activity against other AGC family kinases, including PKA, PKC, ROCK1, RSK1, P70S6K, and SGK. AKT-IN-3 is utilized in cancer research due to its ability to induce apoptosis and inhibit metastasis in cancer cells, making it a valuable tool for exploring therapeutic strategies against malignancies.

    1 mg
    $190.00
    5 mg
    $490.00
    All 6 sizes
  • Chrysotoxine
    Cat. No.
    A25884

    Chrysotoxine

    Chrysotoxine is a dual inhibitor of the Src and Akt signaling pathways. It effectively suppresses cancer stem cell phenotypes by down-regulating the Src/Akt pathway, leading to reduced cell viability and increased apoptosis in H460 and H23 cancer cell lines, while sparing non-tumor cell lines. Due to its rapid excretion and low bioavailability in animal studies, Chrysotoxine serves as a valuable tool in cancer research, particularly for investigating therapies targeting cancer stem cells.

    1 mg
    $105.00
    5 mg
    $245.00
    All 5 sizes
  • Dehydrovomifoliol
    Cat. No.
    A25885

    Dehydrovomifoliol

    Dehydrovomifoliol is a dual inhibitor of the AKT/mTOR signaling pathway. It effectively reduces lipid accumulation and lipogenesis, making it a valuable reagent in the study of nonalcoholic fatty liver disease (NAFLD). The compound's targeted inhibition of AKT and mTOR provides insights into metabolic regulation and potential therapeutic strategies for liver-related disorders.

    1 mg
    $240.00
    5 mg
    $485.00
    All 2 sizes
  • 25(R,S)-Ruscogenin
    Cat. No.
    A25887

    25(R,S)-Ruscogenin

    25(R,S)-Ruscogenin is a potent inhibitor of the PI3K/Akt/mTOR and TLR4 signaling pathways. This compound effectively suppresses hepatocellular carcinoma (HCC) metastasis by decreasing the expression of matrix metalloproteinases (MMP-2 and MMP-9), uPA, VEGF, and HIF-1α. Additionally, 25(R,S)-Ruscogenin mitigates LPS-induced apoptosis in pulmonary endothelial cells, highlighting its potential for applications in cancer research and inflammatory disease studies.

    1 mg
    $35.00
    5 mg
    $80.00
    All 6 sizes
  • M2698
    Cat. No.
    A25894

    M2698

    Synonyms: MSC2363318A

    M2698 is a selective inhibitor targeting p70S6K and Akt, functioning through an ATP-competitive mechanism. With IC50 values of 1 nM for both p70S6K and Akt1/Akt3, M2698 demonstrates potent inhibitory effects on these kinases. This compound is capable of crossing the blood-brain barrier, making it a valuable tool for research in cancer biology and potential therapeutic applications in neurologic conditions.

    1 mg
    $35.00
    5 mg
    $90.00
    All 7 sizes
  • AKT Kinase Inhibitor hydrochloride
    Cat. No.
    A25901

    AKT Kinase Inhibitor hydrochloride

    AKT Kinase Inhibitor hydrochloride is a selective inhibitor of AKT kinase, primarily known for its anti-tumor properties. This compound demonstrates significant potential in cancer research by disrupting the AKT signaling pathway, which is often activated in various malignancies. Additionally, it features an alkyne functional group, facilitating its use in click chemistry applications, particularly in copper-catalyzed azide-alkyne cycloaddition (CuAAc) reactions with azide-containing molecules.

    5 mg
    $345.00
    10 mg
    $605.00
    All 5 sizes
  • AKT-IN-6
    Cat. No.
    A25902

    AKT-IN-6

    AKT-IN-6 is a potent inhibitor of the AKT family of serine/threonine kinases, specifically targeting Akt1, Akt2, and Akt3 with IC50 values of less than 500 nM. This compound is widely utilized in biochemical research to elucidate the role of AKT signaling in various cellular processes, including cell growth, metabolism, and apoptosis. AKT-IN-6 serves as a valuable tool for investigating therapeutic approaches in cancer, diabetes, and neurodegenerative diseases where AKT activity is dysregulated.

    1 mg
    $25.00
    5 mg
    $55.00
    All 7 sizes
  • FPA-124
    Cat. No.
    A25903

    FPA-124

    FPA-124 is a selective Akt inhibitor that operates by targeting both the pleckstrin homology (PH) and kinase domains of Akt. With an IC50 of 0.1 μM, FPA-124 demonstrates significant biological activity in promoting apoptosis. This compound is primarily utilized in research applications focused on cancer biology and signaling pathways associated with the Akt protein.

    1 mg
    $60.00
    5 mg
    $155.00
    All 7 sizes
  • A-674563 hydrochloride
    Cat. No.
    A25907

    A-674563 hydrochloride

    A-674563 hydrochloride is a selective inhibitor of Akt1, exhibiting a Ki value of 11 nM. This compound effectively disrupts Akt1 signaling, making it a valuable tool for investigating the role of this kinase in cellular processes such as metabolism, survival, and proliferation. A-674563 hydrochloride is suitable for use in various research applications, including cancer research and studies focused on metabolic disorders.

    1 mg
    $60.00
    2 mg
    $90.00
    All 4 sizes
  • (E)-Akt inhibitor-IV
    Cat. No.
    A25910

    (E)-Akt inhibitor-IV

    Synonyms: (E)-AKTIV

    (E)-Akt inhibitor-IV is a potent PI3K-Akt inhibitor that selectively targets the Akt signaling pathway. It demonstrates significant cytotoxic activity against various cancer cell lines, making it a valuable tool for studying tumor biology and therapeutic resistance. Research applications include investigating the role of Akt in cell proliferation, survival, and apoptosis in cancer models.

    1 mg
    $40.00
    5 mg
    $95.00
    All 7 sizes
  • Tanerasertib
    Cat. No.
    A25935

    Tanerasertib

    Tanerasertib is an inhibitor of AKT1, specifically targeting the AKT1E17K mutant with an EC50 range of 15-60 nM. This compound exhibits significant biological activity that may be leveraged in cancer research, particularly in studies focusing on the role of the AKT signaling pathway in tumorigenesis and treatment resistance. Its application in preclinical models can provide insights into therapeutic strategies for cancers harboring AKT1 mutations.

    5 mg
    $640.00
    10 mg
    $1,050.00
    All 5 sizes
  • K-80003
    Cat. No.
    A25936

    K-80003

    Synonyms: TX-803

    K-80003 is a potent Akt inhibitor that specifically targets and inhibits tRXRα-dependent Akt activation. This compound exhibits significant biological activity in suppressing cancer cell growth, making it valuable in cancer research. K-80003 is useful for studies investigating Akt signaling pathways and therapeutic strategies against malignancies.

    2 mg
    $30.00
    5 mg
    $50.00
    All 7 sizes
  • 1-Formyl-beta-carboline
    Cat. No.
    A25939

    1-Formyl-beta-carboline

    1-Formyl-beta-carboline is an alkaloid that functions as an Akt inhibitor, disrupting key signaling pathways. It demonstrates significant inhibitory activity against Newcastle disease virus (NDV), with IC50 values below 10 μM and over 90% inhibition at 20 μM concentration. The compound primarily targets the adsorption and entry phases of the NDV life cycle by directly interacting with the NDV hemagglutinin-neuraminidase (HN) protein. Additionally, 1-Formyl-beta-carboline affects viral entry through modulation of the PI3K/Akt signaling pathway.

    1 mg
    $20.00
    5 mg
    $25.00
    All 6 sizes
  • Hu7691
    Cat. No.
    A25940

    Hu7691

    Hu7691 is a selective Akt inhibitor that exhibits potent inhibitory activity with IC50 values of 4.0 nM, 97.5 nM, and 28 nM against Akt1, Akt2, and Akt3, respectively. This compound has been shown to inhibit tumor growth while reducing cutaneous toxicity in mouse models, making it a valuable tool for cancer research. Its specificity and efficacy position Hu7691 as a promising reagent for studies focused on the Akt signaling pathway and its role in tumorigenesis.

    5 mg
    $720.00
    10 mg
    $1,225.00
    All 3 sizes
  • Vevorisertib
    Cat. No.
    A25941

    Vevorisertib

    Synonyms: ARQ 751

    Vevorisertib is a potent and selective pan-AKT serine/threonine kinase inhibitor, effectively targeting AKT1 (IC50=0.55 nM), AKT2 (IC50=0.81 nM), and AKT3 (IC50=1.31 nM). This orally active compound demonstrates significant biological activity in inhibiting AKT pathways and is applicable in the study of solid tumors harboring PIK3CA, AKT, or PTEN mutations. Vevorisertib can be utilized as a monotherapy or in combination with other anti-cancer agents for enhanced therapeutic efficacy in cancer research.

    1 mg
    $130.00
    5 mg
    $325.00
    All 5 sizes
  • GSK2110183 analog 1 hydrochloride
    Cat. No.
    A25948

    GSK2110183 analog 1 hydrochloride

    GSK2110183 analog 1 hydrochloride is a structural analogue designed to inhibit Akt, a critical signaling protein involved in various cellular processes such as growth, survival, and metabolism. This compound demonstrates potent Akt inhibitory activity, making it a valuable tool for studying the role of Akt in cancer progression and treatment. Its applications extend to exploring therapeutic strategies targeting the Akt pathway in various disease models.

    5 mg
    $345.00
    10 mg
    $505.00
    All 4 sizes
  • AKT inhibitor IV
    Cat. No.
    A25953

    AKT inhibitor IV

    Synonyms: AKTIV

    AKT Inhibitor IV is a potent PI3K-Akt pathway inhibitor that selectively targets the E isomer. This compound exhibits significant cytotoxic effects, making it valuable for research applications focusing on cell proliferation, survival, and apoptosis. It is ideal for studies investigating the role of the PI3K-Akt signaling pathway in cancer and other diseases.

    1 mg
    $75.00
    All 1 sizes
  • CCT128930 hydrochloride
    Cat. No.
    A25956

    CCT128930 hydrochloride

    CCT128930 hydrochloride is a selective inhibitor of AKT, demonstrating an IC50 of 6 nM. It exhibits significant selectivity, being 28-fold more potent against AKT than the closely related PKA kinase (IC50 of 168 nM) and 20-fold more effective than p70S6K (IC50 of 120 nM). CCT128930 hydrochloride is recognized for its ability to induce cell cycle arrest, promote DNA damage, and stimulate autophagy, enabling its application in cancer research and potential antitumor strategies.

    1 mg
    $35.00
    5 mg
    $80.00
    All 7 sizes
  • Pifusertib
    Cat. No.
    A25957

    Pifusertib

    Synonyms: TAS-117

    Pifusertib is a selective, orally active allosteric inhibitor of Akt, exhibiting IC50 values of 4.8, 1.6, and 44 nM for Akt1, Akt2, and Akt3, respectively. This compound demonstrates significant anti-myeloma activity and intensifies lethal endoplasmic reticulum (ER) stress resulting from proteasome inhibition. In addition, Pifusertib promotes both apoptosis and autophagy, making it a useful tool for research in cancer biology and therapeutic development.

    5 mg
    $490.00
    10 mg
    $880.00
    All 3 sizes
  • MK-2206
    Cat. No.
    A25970

    MK-2206

    MK-2206 is a highly potent and selective allosteric inhibitor of the Akt signaling pathway, exhibiting IC50 values of 8, 12, and 65 nM for Akt1, Akt2, and Akt3, respectively. This compound demonstrates significant anticancer activity, particularly in breast cancer cell lines and those harboring PIK3CA mutations or loss of PTEN function. MK-2206 is valuable for research investigating Akt's role in cancer progression and therapeutic resistance.

    5 mg
    $565.00
    10 mg
    $925.00
    All 5 sizes
  • Engasertib
    Cat. No.
    A25982

    Engasertib

    Synonyms: ALM301

    Engasertib is a potent and selective inhibitor of AKT1 and AKT2, displaying IC50 values of 0.13 µM and 0.09 µM, respectively, with a slightly lower potency against AKT3 at 2.75 µM. This compound effectively inhibits AKT phosphorylation, leading to modulation of downstream signaling pathways in vitro. Due to its ability to suppress cancer cell proliferation and tumor growth, Engasertib serves as a valuable tool for cancer research and therapeutic development.

    5 mg
    $295.00
    10 mg
    $485.00
    All 5 sizes
  • Notoginsenoside Ft1
    Cat. No.
    A26006

    Notoginsenoside Ft1

    Notoginsenoside Ft1 is a potent PI3K/AKT/mTOR inhibitor with significant bioactive properties. This compound induces apoptosis and lysosomal cell death in various cancer cell types by modulating key signaling pathways, such as p38 MAPK and ERK1/2, while promoting angiogenesis. Additionally, Notoginsenoside Ft1 enhances CD8+ T cell populations and exerts vasodilatory effects through glucocorticoid and estrogen receptor beta activation in endothelial cells. By acting as a TGR5 agonist and FXR antagonist, it may provide protective effects against renal injury and contribute to the management of obesity and insulin resistance through the modulation of intracellular calcium and cAMP levels.

    5 mg
    $65.00
    10 mg
    $85.00
    All 2 sizes
  • Vevorisertib trihydrochloride
    Cat. No.
    A26009

    Vevorisertib trihydrochloride

    Synonyms: ARQ 751 trihydrochloride

    Vevorisertib trihydrochloride is a selective, allosteric inhibitor targeting pan-AKT and the AKT1-E17K mutant. It effectively inhibits AKT phosphorylation, demonstrating Kd values of 1.2 nM for AKT1 and 8.6 nM for AKT1-E17K, along with IC50 values of 0.55 nM, 0.81 nM, and 1.3 nM for AKT1, AKT2, and AKT3, respectively. This compound is valuable for cancer research, aiding in the exploration of therapeutic strategies targeting the AKT signaling pathway.

    1 mg
    $50.00
    5 mg
    $120.00
    All 6 sizes
  • Pifusertib hydrochloride
    Cat. No.
    A26013

    Pifusertib hydrochloride

    Synonyms: TAS-117 hydrochloride

    Pifusertib hydrochloride is a selective allosteric inhibitor of Akt, exhibiting IC50 values of 4.8 nM, 1.6 nM, and 44 nM for Akt1, Akt2, and Akt3, respectively. This compound demonstrates significant anti-myeloma activity by enhancing endoplasmic reticulum stress in the context of proteasome inhibition. Additionally, Pifusertib hydrochloride induces both apoptosis and autophagy, making it a valuable tool for research into cancer therapies and the modulation of cellular stress responses.

    5 mg
    $490.00
    10 mg
    $880.00
    All 3 sizes

Items 126-150 of 158

Added to your cart

View Cart Checkout

    Loading...